Superluminal Medicines, Inc. funding
Superluminal Medicines, Inc., a biotechnology company based in Boston, MA (founded 2023), filed a Form D with the SEC on September 3, 2026 and reported $65.5M raised.
Amount raised$65.5M
Offering size$65.5M
Filed with the SECSeptember 3, 2026
First saleAugust 10, 2026
IndustryBiotechnology
SecuritiesEquity
LocationBoston, MA
Founded2023
Entity typeCorporation
Investors so far16
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Sep 3
Other health care rounds in Massachusetts
Zai Lab Ltd$250M · Nov 9BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21BiotechnologyAI3 Bio, Inc.$48.3M · Nov 4BiotechnologyNanopath Inc$29.9M · Nov 13BiotechnologyXRHealth, Inc.$22.8M · Sep 16Other Health CareXact Bio, Inc.$10M · Sep 28BiotechnologyCrosslink Therapeutics Inc.$5.5M · Oct 20PharmaceuticalsFresenius Medical Care Fulshear, LLC$4.4M · Oct 21Other Health Care